Short-term effect of atorvastatin in hypercholesterolaemic renal-transplant patients unresponsive to other statins

Nephrology Dialysis Transplantation

Volumn 15, Issue 9, 2000, Pages 1446-1449

  Romero, Rafael ^a   Calviño, Jesus ^a   Rodriguez, Javier ^a   Sánchez Guisande, Domingo ^a  

^a University Hospital of Santiago de Compostela   (Spain)

Author keywords

Atorvastatin; HMG CoA reductase inhibitor; Hyperlipidaemia; Renal transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; CREATINE KINASE; CREATININE; CYCLOSPORIN A; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STEROID; TRIACYLGLYCEROL;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; HYPERCHOLESTEROLEMIA; KIDNEY TRANSPLANTATION; MALE; MYOSITIS; NAUSEA; PRIORITY JOURNAL; RECIPIENT; RHABDOMYOLYSIS;

EID: 0033824836     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.9.1446     Document Type: Article

References (16)

1. Posttransplant hyperlipidemia: The treatment dilemma
2. Treatment of hyperlipidemia in renal transplant recipients
3. Persistent hyperlipidemia in renal transplant recipients
4. Lipid-lowering therapy in patients with renal disease
5. The effects of the American Heart Association step 1 diet on hyperlipidemia following renal transplantation
6. Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: Are the statins mechanistically similar?
7. Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias
8. Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor
9. An overview of the clinical safety profile of atorvastatin (Lipitor), a new. HMG-CoA reductase inhibitor
10. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults. The Expert Panel
11. Clinical correlates to chronic renal allograft rejection
12. Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolemia
13. 2 cholesterol
14. Lipoprotein
15. HMG-CoA-reductase inhibitors lower LDL-cholesterol without reducing Lp (a) levels
16. Comparison of statins in hypertriglyceridemia